Biljana Nadjsombati Email

VP, Pharmaceutical Development . Viracta Therapeutics (formerly Sunesis)

Current Roles

Employees:
52
Revenue:
$5.9M
About
Viracta is focused on advancing a proprietary viral gene activation therapy to address cancers associated with the Epstein-Barr Virus, and will pursue opportunities to address other serious virus-associated disease.
Viracta Therapeutics (formerly Sunesis) Address
2533 S. Coast Hwy 101
Cardiff-by-the-Sea, CA
United States
Viracta Therapeutics (formerly Sunesis) Email
Viracta Therapeutics (formerly Sunesis) Phone Numbers
858-400-8470

Past Companies

Viracta Therapeutics, Inc.Vice President, Pharmaceutical Development
Urovant Sciences, Inc.Vice President, Chemistry, Manufacturing and Controls (CMC)
Avanir PharmaceuticalsExecutive Director, Pharmaceutical Development and Supply Chain

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.